Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erik Winter"'
Autor:
Stefan Alexander Koerber, Erik Winter, Sonja Katayama, Alla Slynko, Matthias Felix Haefner, Matthias Uhl, Florian Sterzing, Gregor Habl, Kai Schubert, Juergen Debus, Klaus Herfarth
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: This prospective, non-randomized phase II trial aimed to investigate the role of additional irradiation of the pelvic nodes for patients with prostate cancer and a high risk for nodal metastases using helical intensity-modulated radioth
Externí odkaz:
https://doaj.org/article/af7c19db2cac4b658062d231529b7946
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 50:2226-2227
Autor:
Erik Winter, Peter L. Choyke, Irfan A. Bhatti, Clemens Kratochwil, Frederik L. Giesel, M. Syed, Thomas Lindner, Guy Ungerechts, Uwe Haberkorn, Stefan A. Koerber, Klaus Herfarth, Juergen Debus, Matthias F. Haefner, Dirk Jaeger, Fabian Staudinger, Hendrik Rathke, Sebastian Adeberg
Publikováno v:
J Nucl Med
For oncologic management or radiotherapy planning, reliable staging tools are essential. The recent development of quinoline-based ligands targeting cancer-associated fibroblasts demonstrated promising preclinical and clinical results. The current st
Autor:
Clemens Kratochwil, Stefanie Zschaebitz, Frederik L. Giesel, Klaus Herfarth, Markus Hohenfellner, Erik Winter, Ingmar Schlampp, Juergen Debus, Luisa Hofer, Stefan A. Koerber, Uwe Haberkorn, Johannes Boesch, Dirk Jaeger, Klaus Kopka, Tim Holland-Letz, Jonas Ristau
Publikováno v:
Cancers
Volume 13
Issue 7
Cancers, Vol 13, Iss 1508, p 1508 (2021)
Cancers 13(2021), 1508
Volume 13
Issue 7
Cancers, Vol 13, Iss 1508, p 1508 (2021)
Cancers 13(2021), 1508
Men diagnosed with aggressive prostate cancer are at high risk of local relapse or systemic progression after definitive treatment. Treatment intensification is highly needed for that patient cohort
however, no relevant stratification tool has b
however, no relevant stratification tool has b
Autor:
J. Ristau, Jürgen Debus, Frederik L. Giesel, Thomas Lindner, Clemens Kratochwil, Erik Winter, Fabian Staudinger, Klaus Herfarth, Matthias F. Haefner, H Rathke, S Körber, Sebastian Adeberg, Uwe Haberkorn
Publikováno v:
58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Autor:
Ingmar Schlampp, Tim Holland-Letz, Klaus Kopka, Frederik L. Giesel, Erik Winter, Stefan A. Koerber, Stefanie Zschaebitz, Clemens Kratochwil, Katharina Sprute, Ali Afshar-Oromieh, Juergen Debus, Markus Hohenfellner, Peter L. Choyke, Matthias F. Haefner, Dirk Jaeger, Uwe Haberkorn, Sonja Katayama, Klaus Herfarth
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging (2020)
European Journal of Nuclear Medicine and Molecular Imaging 48(2021), 143-151
European Journal of Nuclear Medicine and Molecular Imaging (2020)
European Journal of Nuclear Medicine and Molecular Imaging 48(2021), 143-151
Purpose First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomograp
Autor:
Stefan A. Koerber, Katharina Sprute, Clemens Kratochwil, Erik Winter, Matthias F. Haefner, Sonja Katayama, Ingmar Schlampp, Klaus Herfarth, Klaus Kopka, Ali Afshar-Oromieh, Stefanie Zschaebitz, Tim Holland-Letz, Peter L. Choyke, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus, Frederik L. Giesel
Publikováno v:
European Journal of Nuclear Medicine & Molecular Imaging; 2021, Vol. 48 Issue 1, p143-151, 9p, 1 Color Photograph, 4 Charts, 3 Graphs